Check out Pro
Top CompaniesRecent TradesCluster BuysSectorsBlog
Join the Insiderviz Pro waitlist
Altimmune, Inc. (ALT)
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
15 Aug 2023
Drutz David
Director
Altimmune, Inc.
(ALT)
29,785+1%
300
$2.88
$862.50
BUY
24 Mar 2023
Eisenstadt Richard I
Chief Financial Officer, Officer
Altimmune, Inc.
(ALT)
22,010+83%
10,000
$4.31
$43,140.00
BUY
23 Mar 2023
Harris Matthew Scott
Chief Medical Officer, Officer
Altimmune, Inc.
(ALT)
33,311+42%
10,000
$4.22
$42,200.00
BUY
23 Mar 2023
Drutz David
Director
Altimmune, Inc.
(ALT)
29,484+43%
9,000
$4.27
$38,430.00
SELL
22 Dec 2022
Pisano Wayne
Director
Altimmune, Inc.
(ALT)
8,498-70%
20,000
$15.01
$300,268.00
SELL
30 Aug 2022
Garg Vipin K
President and CEO, Director, Officer
Altimmune, Inc.
(ALT)
236,797-7%
20,000
$20.02
$400,322.00
SELL
12 Aug 2022
Garg Vipin K
President and CEO, Director, Officer
Altimmune, Inc.
(ALT)
259,804-5%
15,000
$15.06
$225,889.50
SELL
12 Aug 2022
GILL JOHN
Director
Altimmune, Inc.
(ALT)
2,771-49%
2,714
$15.00
$40,710.00
SELL
1 Jul 2022
Roberts M Scot
Chief Scientific Officer, Officer
Altimmune, Inc.
(ALT)
8,305-81%
37,164
$12.00
$445,968.00
SELL
29 Jun 2022
Roberts M Scot
Chief Scientific Officer, Officer
Altimmune, Inc.
(ALT)
17,700-23%
5,462
$12.00
$65,546.18
SELL
27 Jun 2022
Roberts M Scot
Chief Scientific Officer, Officer
Altimmune, Inc.
(ALT)
17,700-67%
37,352
$12.00
$448,253.88
SELL
27 Jun 2022
Jorkasky Diane
Director
Altimmune, Inc.
(ALT)
0-100%
17,610
$11.75
$206,943.92
BUY
15 Jun 2022
Drutz David
Director
Altimmune, Inc.
(ALT)
20,012+5%
1,000
$8.00
$8,000.00
BUY
24 May 2022
Drutz David
Director
Altimmune, Inc.
(ALT)
19,012+6%
1,200
$4.50
$5,400.00
SELL
28 Feb 2022
Harris Matthew Scott
Chief Medical Officer, Officer
Altimmune, Inc.
(ALT)
11,545-72%
30,000
$7.52
$225,600.00
SELL
1 Mar 2021
Hodges Philip
Director
Altimmune, Inc.
(ALT)
8,731-40%
6,000
$16.08
$96,480.00
BUY
10 Dec 2020
Schafer Klaus
Director
Altimmune, Inc.
(ALT)
8,900+28%
2,000
$11.99
$23,980.00
SELL
30 Nov 2020
GILL JOHN
Director
Altimmune, Inc.
(ALT)
11,199-42%
8,425
$11.92
$100,426.00
SELL
30 Nov 2020
Hodges Philip
Director
Altimmune, Inc.
(ALT)
0-100%
3,727
$12.51
$46,613.58
SELL
12 Nov 2020
Schafer Klaus
Director
Altimmune, Inc.
(ALT)
6,900-59%
10,150
$9.91
$100,586.50
SELL
12 Nov 2020
Pisano Wayne
Director
Altimmune, Inc.
(ALT)
8,498-54%
10,352
$9.90
$102,484.80
SELL
12 Nov 2020
Harris Matthew Scott
Director
Altimmune, Inc.
(ALT)
4,069-49%
4,015
$10.02
$40,230.30
BUY
15 Jun 2020
Venrock Healthcare Capital Partners III, L.P.
10% Owner
Altimmune, Inc.
(ALT)
4,500,000+50%
1,500,000
$7.54
$11,310,000.00
BUY
26 May 2020
Venrock Healthcare Capital Partners III, L.P.
10% Owner
Altimmune, Inc.
(ALT)
2,826,289+85%
1,303,636
$8.74
$11,395,492.00
SELL
14 May 2020
VELOCITY PHARMACEUTICAL HOLDINGS LLC
10% Owner
Altimmune, Inc.
(ALT)
1,687,250-10%
200,000
$4.79
$957,100.50
BUY
5 Sep 2019
Garg Vipin K
President and CEO, Director, Officer
Altimmune, Inc.
(ALT)
342,907+6%
20,000
$2.10
$42,000.00
BUY
9 Oct 2018
Pisano Wayne
Director
Altimmune, Inc.
(ALT)
2,000+100%
2,000
$4.59
$9,180.00
BUY
25 May 2018
Enright William
President and CEO, Director, Officer
Altimmune, Inc.
(ALT)
365,839+0%
43.333
$15.23
$659.88
BUY
29 Dec 2017
SAYARE MITCHEL
Director
Altimmune, Inc.
(ALT)
32,650+0%
170
$58.61
$9,962.85
BUY
28 Dec 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
589,453+0%
3,247
$57.73
$187,450.36
BUY
22 Dec 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
464,337+1%
4,904.334
$52.88
$259,356.40
BUY
6 Dec 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
344,913+0%
791.5
$53.45
$42,303.53
BUY
1 Dec 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
321,168+0%
867
$53.73
$46,587.57
BUY
28 Nov 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
295,158+0%
1,110.5
$57.31
$63,638.65
BUY
22 Nov 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
261,843+0%
726.933
$60.92
$44,282.19
BUY
17 Nov 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
240,035+0%
611.033
$62.54
$38,214.73
BUY
24 Aug 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
221,704+1%
2,244.2
$67.41
$151,281.69
BUY
22 Aug 2017
Drutz David
Director
Altimmune, Inc.
(ALT)
30,777+1%
333.333
$66.29
$22,097.00
BUY
21 Aug 2017
SCHAFFER DERACE L
Director
Altimmune, Inc.
(ALT)
154,378+1%
1,666.667
$66.16
$110,263.47
BUY
6 Jun 2017
Roberts M Scot
Chief Scientific Officer, Officer
Altimmune, Inc.
(ALT)
449+3%
14.967
$132.60
$1,984.58
BUY
2 Jun 2017
GILL JOHN
Director
Altimmune, Inc.
(ALT)
83,224+0%
33.333
$130.31
$4,343.50
SELL
7 Dec 2016
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
10% Owner
PHARMATHENE, INC
(PIP)
6,626,403-0%
45,154.402
$97.70
$4,411,695.50
SELL
13 Apr 2016
RICHMAN ERIC I
Director
PHARMATHENE, INC
(PIP)
176,822-5%
10,978.467
$66.00
$724,578.80
SELL
7 Apr 2016
RICHMAN ERIC I
Director
PHARMATHENE, INC
(PIP)
176,822-0%
392.233
$66.00
$25,887.40
Home
Top CompaniesForm ScreenerSectors
DisclaimersPrivacyTerms of Service
ContactBlogNewsletter